Smith & Nephew PLC (SNN)
24.01
+0.09
(+0.38%)
USD |
NYSE |
Apr 18, 16:00
24.01
0.00 (0.00%)
Pre-Market: 20:00
Smith & Nephew Market Cap: 10.50B for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 10.50B |
| April 17, 2024 | 10.46B |
| April 16, 2024 | 10.40B |
| April 15, 2024 | 10.40B |
| April 12, 2024 | 10.39B |
| April 11, 2024 | 10.72B |
| April 10, 2024 | 10.64B |
| April 09, 2024 | 10.78B |
| April 08, 2024 | 10.64B |
| April 05, 2024 | 10.70B |
| April 04, 2024 | 10.64B |
| April 03, 2024 | 10.76B |
| April 02, 2024 | 10.61B |
| April 01, 2024 | 10.73B |
| March 28, 2024 | 11.09B |
| March 27, 2024 | 11.51B |
| March 26, 2024 | 11.40B |
| March 25, 2024 | 11.30B |
| March 22, 2024 | 11.45B |
| March 21, 2024 | 11.40B |
| March 20, 2024 | 11.55B |
| March 19, 2024 | 11.77B |
| March 18, 2024 | 11.66B |
| March 15, 2024 | 11.81B |
| March 14, 2024 | 12.01B |
| Date | Value |
|---|---|
| March 13, 2024 | 12.16B |
| March 12, 2024 | 12.24B |
| March 11, 2024 | 12.21B |
| March 08, 2024 | 12.09B |
| March 07, 2024 | 12.04B |
| March 06, 2024 | 11.99B |
| March 05, 2024 | 11.64B |
| March 04, 2024 | 11.58B |
| March 01, 2024 | 11.55B |
| February 29, 2024 | 11.59B |
| February 28, 2024 | 11.55B |
| February 27, 2024 | 12.22B |
| February 26, 2024 | 12.47B |
| February 23, 2024 | 12.63B |
| February 22, 2024 | 12.62B |
| February 21, 2024 | 12.49B |
| February 20, 2024 | 12.45B |
| February 16, 2024 | 12.27B |
| February 15, 2024 | 12.25B |
| February 14, 2024 | 12.12B |
| February 13, 2024 | 12.03B |
| February 12, 2024 | 12.18B |
| February 09, 2024 | 12.17B |
| February 08, 2024 | 12.24B |
| February 07, 2024 | 12.32B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.411B
Minimum
Oct 26 2023
22.60B
Maximum
Feb 20 2020
15.45B
Average
15.47B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 211.94B |
| Adaptimmune Therapeutics PLC | 221.75M |
| Biodexa Pharmaceuticals Plc | 3.485M |
| Verona Pharma PLC | 1.303B |
| NuCana PLC | 8.394M |
Market Cap Related Metrics
| PE Ratio | 39.88 |
| PS Ratio | 1.890 |
| Price to Book Value | 2.012 |
| Price | 24.01 |
| Earnings Yield | 2.51% |
| Operating PE Ratio | 15.89 |
| Normalized PE Ratio | 39.88 |